Skip to main content
Frontiers in Cell and Developmental Biology logoLink to Frontiers in Cell and Developmental Biology
. 2024 Oct 16;12:1461581. doi: 10.3389/fcell.2024.1461581

Corrigendum: Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis

Christian Stoess 1,2, Aleksandra Leszczynska 1, Lin Kui 1, Ariel E Feldstein 1,*
PMCID: PMC11522226  PMID: 39479516

In the published article, there was an error in the Conflict of interest statement-author, Ariel E. Feldstein was erroneously excluded. The corrected Conflict of interest statement appears below.

“Author AEF is an employee and stockholder of Novo Nordisk.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The author apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Cell and Developmental Biology are provided here courtesy of Frontiers Media SA

RESOURCES